Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI8852 in adults with acute, uncomplicated influenza
NCT02603952Phase 2Completed
- Sponsor
- MedImmune
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of MEDI8852 in Influenza A (IAV), sponsored by MedImmune. Started Dec 2015; status: completed.
02
Drugs
MEDI8852
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT02603952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603952.